levonorgestrel-releasing intrauterine system
Term · Oncology and biomedicine · MLC-T-ONC-014766
A long-acting, hormone-releasing, intrauterine device consisting of a small, T-shaped, polyethylene frame and a reservoired synthetic progesterone with progestational and potential antineoplastic activities. After insertion of this system into the uterus, the device slowly and gradually releases the hormone. Levonorgestrel acts by binding to the progesterone receptor in the nuclei of target cells, resulting in transcription activation and an alteration in protein synthesis. Subsequently, luteinizing hormone (LH) activity and ovulation are suppressed. Levonorgestrel may also exhibit antiproliferative activity in endometrial tissue.
| Identifier | MLC-T-ONC-014766 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | LNG-IUS |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-014766",
"term": "levonorgestrel-releasing intrauterine system",
"field": "Oncology and biomedicine",
"definition": "A long-acting, hormone-releasing, intrauterine device consisting of a small, T-shaped, polyethylene frame and a reservoired synthetic progesterone with progestational and potential antineoplastic activities. After insertion of this system into the uterus, the device slowly and gradually releases the hormone. Levonorgestrel acts by binding to the progesterone receptor in the nuclei of target cells, resulting in transcription activation and an alteration in protein synthesis. Subsequently, luteinizing hormone (LH) activity and ovulation are suppressed. Levonorgestrel may also exhibit antiproliferative activity in endometrial tissue.",
"abbreviation": "LNG-IUS",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/levonorgestrel-releasing-intrauterine-system/"
}
Record 10,067 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.